These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 31554462

  • 1. Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.
    Xian Y, Navar AM, Li S, Li Z, Robinson J, Virani SS, Louie MJ, Koren A, Goldberg A, Roger VL, Wilson PWF, Peterson ED, Wang TY.
    J Am Heart Assoc; 2019 Oct; 8(19):e013229. PubMed ID: 31554462
    [Abstract] [Full Text] [Related]

  • 2. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
    Virani SS, Kennedy KF, Akeroyd JM, Morris PB, Bittner VA, Masoudi FA, Stone NJ, Petersen LA, Ballantyne CM.
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004652. PubMed ID: 29748356
    [Abstract] [Full Text] [Related]

  • 3. Sex Differences in the Use of Statins in Community Practice.
    Nanna MG, Wang TY, Xiang Q, Goldberg AC, Robinson JG, Roger VL, Virani SS, Wilson PWF, Louie MJ, Koren A, Li Z, Peterson ED, Navar AM.
    Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005562. PubMed ID: 31416347
    [Abstract] [Full Text] [Related]

  • 4. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž, De Backer G, Fras Z, Kotseva K, Tokgözoglu L, Wood D, De Bacquer D, EUROASPIRE Investigators.
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [Abstract] [Full Text] [Related]

  • 5. Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry.
    Nanna MG, Navar AM, Wang TY, Li S, Virani SS, Li Z, Robinson JG, Roger VL, Wilson PWF, Goldberg AC, Koren A, Louie MJ, Peterson ED.
    Am Heart J; 2019 Aug; 214():113-124. PubMed ID: 31202098
    [Abstract] [Full Text] [Related]

  • 6. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J, Rajalingam T, Fossella J, Zhou H, Eisenberg N, Roche-Nagle G.
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [Abstract] [Full Text] [Related]

  • 7. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
    März W, Dippel FW, Theobald K, Gorcyca K, Iorga ŞR, Ansell D.
    Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
    [Abstract] [Full Text] [Related]

  • 8. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E, Rittner SS, Carroll JE, Crawford PM, Dant L, Laws R, Leo MC, Puro J, Persell SD.
    J Am Heart Assoc; 2017 Jul 03; 6(7):. PubMed ID: 28673901
    [Abstract] [Full Text] [Related]

  • 9. Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics.
    Morieri ML, Avogaro A, Fadini GP, the DARWIN-T2D Network of the Italian Diabetes Society.
    Cardiovasc Diabetol; 2020 Nov 10; 19(1):190. PubMed ID: 33172454
    [Abstract] [Full Text] [Related]

  • 10. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T, Zhou S, Anzalone D, Kern DM, Tunceli O, Cziraky MJ, Willey VJ.
    J Am Heart Assoc; 2017 May 04; 6(5):. PubMed ID: 28473405
    [Abstract] [Full Text] [Related]

  • 11. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
    Arca M, Ansell D, Averna M, Fanelli F, Gorcyca K, Iorga ŞR, Maggioni AP, Paizis G, Tomic R, Catapano AL.
    Atherosclerosis; 2018 Apr 04; 271():120-127. PubMed ID: 29499359
    [Abstract] [Full Text] [Related]

  • 12. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.
    Fox KM, Tai MH, Kostev K, Hatz M, Qian Y, Laufs U.
    Clin Res Cardiol; 2018 May 04; 107(5):380-388. PubMed ID: 29273856
    [Abstract] [Full Text] [Related]

  • 13. Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries.
    Colivicchi F, Massimo Gulizia M, Arca M, Luigi Temporelli P, Gonzini L, Venturelli V, Morici N, Indolfi C, Gabrielli D, De Luca L.
    Cardiovasc Ther; 2020 May 04; 2020():3856242. PubMed ID: 31969932
    [Abstract] [Full Text] [Related]

  • 14. Temporal Trends of High-Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention.
    Bin Abdulhak AA, Vaughan-Sarrzin M, Kaboli P, Horwitz PA, Mosher H, Sigurdsson G, Walker NE, Wallace R, Robinson JG.
    J Am Heart Assoc; 2018 Mar 04; 7(5):. PubMed ID: 29503265
    [Abstract] [Full Text] [Related]

  • 15. Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China.
    Wang X, He Y, Wang T, Li C, Ma Z, Zhang H, Ma H, Zhao H.
    J Cardiovasc Pharmacol Ther; 2020 Jul 04; 25(4):307-315. PubMed ID: 31918567
    [Abstract] [Full Text] [Related]

  • 16. Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry.
    Nanna MG, Navar AM, Zakroysky P, Xiang Q, Goldberg AC, Robinson J, Roger VL, Virani SS, Wilson PWF, Elassal J, Lee LV, Wang TY, Peterson ED.
    JAMA Cardiol; 2018 Aug 01; 3(8):739-748. PubMed ID: 29898219
    [Abstract] [Full Text] [Related]

  • 17. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
    Munkhaugen J, Sverre E, Otterstad JE, Peersen K, Gjertsen E, Perk J, Gullestad L, Moum T, Dammen T, Husebye E.
    Eur J Prev Cardiol; 2017 Jun 01; 24(9):981-989. PubMed ID: 28196429
    [Abstract] [Full Text] [Related]

  • 18. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
    Nanna MG, Navar AM, Wang TY, Mi X, Virani SS, Louie MJ, Lee LV, Goldberg AC, Roger VL, Robinson J, Peterson ED.
    J Am Heart Assoc; 2018 May 08; 7(10):. PubMed ID: 29739801
    [Abstract] [Full Text] [Related]

  • 19. Sex disparity persists in the prevention of cardiovascular disease in women on statin therapy compared to that in men.
    Moreno-Arellano S, Delgado-de-Mendoza J, Santi-Cano MJ.
    Nutr Metab Cardiovasc Dis; 2018 Aug 08; 28(8):810-815. PubMed ID: 29754716
    [Abstract] [Full Text] [Related]

  • 20. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM, Ahmad ZS, O'Brien EC, Kindt I, Shrader P, Newman CB, Pokharel Y, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW.
    Circ Cardiovasc Genet; 2016 Jun 08; 9(3):240-9. PubMed ID: 27013694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.